VIR logo Vir Biotechnology : VIR

VIR

Stock Data

$10.00

Change down

$0.22 (2.10%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Vir Biotechnology Inc is a pioneering immunology company focused on developing treatments for serious infectious diseases. With a robust pipeline, it targets conditions like chronic hepatitis, HIV, respiratory viruses, influenza, HPV lesions, and COVID-19. The company collaborates with notable organizations and companies, including the Bill & Melinda Gates Foundation, National Institutes of Health, and GlaxoSmithKline, to advance its research and development efforts. Founded in 2016 and based in San Francisco, Vir Biotechnology leverages partnerships and cutting-edge science to create solutions for global health challenges.

All Vir Biotechnology Articles

11 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.